Malaysian Genomics Resource (0155) - Total Liabilities

Latest as of March 2026: RM3.12 Million MYR ≈ $782.07K USD

Based on the latest financial reports, Malaysian Genomics Resource (0155) has total liabilities worth RM3.12 Million MYR (≈ $782.07K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Malaysian Genomics Resource equity growth rate to track the company's year-over-year net asset growth rate.

Malaysian Genomics Resource - Total Liabilities Trend (2015–2026)

This chart illustrates how Malaysian Genomics Resource's total liabilities have evolved over time, based on quarterly financial data. See Malaysian Genomics Resource (0155) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Malaysian Genomics Resource Competitors by Total Liabilities

The table below lists competitors of Malaysian Genomics Resource ranked by their total liabilities.

Company	Country	Total Liabilities
INNEOVA Holdings Limited NASDAQ:INEO	USA	$36.45 Million
Star Diamond Corp TO:DIAM	Canada	CA$7.93 Million
Ainos Inc NASDAQ:AIMD	USA	$13.31 Million
Patria Private Equity Trust LSE:PPET	UK	GBX229.45 Million
M.P.Evans Group LSE:MPE	UK	GBX60.30 Million
Hays plc LSE:HAS	UK	GBX1.30 Billion
Admiralty Resources NL AU:ADY	Australia	AU$18.25 Million
AirIQ Inc V:IQ	Canada	CA$1.09 Million

Liability Composition Analysis (2015–2026)

This chart breaks down Malaysian Genomics Resource's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Malaysian Genomics Resource.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Malaysian Genomics Resource's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Malaysian Genomics Resource (2015–2026)

The table below shows the annual total liabilities of Malaysian Genomics Resource from 2015 to 2026.

Year	Total Liabilities	Change
2026-06-30	RM3.92 Million ≈ $985.33K	-6.55%
2025-06-30	RM4.20 Million ≈ $1.05 Million	+25.12%
2024-06-30	RM3.36 Million ≈ $842.77K	-17.81%
2023-06-30	RM4.08 Million ≈ $1.03 Million	-15.67%
2022-06-30	RM4.84 Million ≈ $1.22 Million	-0.20%
2021-06-30	RM4.85 Million ≈ $1.22 Million	+486.11%
2020-06-30	RM827.98K ≈ $207.88K	-96.07%
2019-06-30	RM21.07 Million ≈ $5.29 Million	+0.01%
2018-06-30	RM21.07 Million ≈ $5.29 Million	+56.14%
2017-06-30	RM13.49 Million ≈ $3.39 Million	+550.16%
2016-06-30	RM2.08 Million ≈ $521.09K	-48.95%
2015-06-30	RM4.07 Million ≈ $1.02 Million	--

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$11.18 Million

RM44.52 Million MYR

Market Cap Rank

#26767 Global

#821 in Malaysia

Share Price

RM0.30

Change (1 day)

+1.72%

52-Week Range

RM0.17 - RM0.30

All Time High

RM2.72